Lindita Shehu

Intensive Care Medicine

1850 Town Center Pkwy
Reston, VA 20190

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 1 publications

Safety and dose-finding study of activated protein C (drotrecogin alfa activated) as an anticoagulant in end-stage renal disease patients treated with hemodialysis.

Safety and dose-finding study of activated protein C (drotrecogin alfa activated) as an anticoagulant in end-stage renal disease patients treated with hemodialysis.

Journal: Blood purification

Published: October 28, 2013

Showing 1-1 of 1

Last Updated: 09/26/2026